Pfizer Inc (#PFE) Stock Price, Live Chart & Analysis | Trade #PFE

Interesting facts about the #PFE (Pfizer Inc)

Pfizer owns numerous brands, including Advil, Celebrex, Bextra, Lyrica, Diflucan, Robitussin, and Viagra. Although the company has been well-known worldwide for years, its popularity increased during the Covid-19 pandemic due to the development of the BioNTech COVID-19 vaccine.

The company’s share history began in 1900 when Pfizer filed an official certificate of incorporation in New Jersey; $2 million of authorized capital was divided into 20,000 shares. The company was private until 1942. In June 1942, the company went public when 240,000 shares of new common stock were offered on the market. Currently, the company’s stocks are traded on the New York Stock Exchange under the #PFE ticker.

Pfizer’s stock price is quite low for buying shares in the company; the dividends are in the top 75% of all US-listed companies. Moreover, the company has been raising its dividends for many years. Pfizer’s revenue and earnings growth have been increasing for years, which is another positive factor in dealing with the company’s stocks. The company is included in various world-leading indices. The most popular ones are S&P 500, DJ Composite, DJ US, and DJ Large-Cap.

However, it can be risky, as pharmaceutical companies are one of the leaders of regulation issues and lawsuits. For example, Pfizer has recalled some of its popular products many times because of quality issues and poor packaging. Although thousands of lawsuits against Pfizer have been dismissed by courts, there have been numerous active lawsuits. There have been many cases caused by claims of illegal marketing and health care fraud, which Pfizer has agreed to settle. In 2009, the company suffered the largest settlement and largest criminal fine out of any health care fraud lawsuit — $2.3 billion.

Thus, it’s worth considering CFD trading, which allows benefiting from the rise and fall of the stock price.